Interleukin 36 gamma | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

4,911 results for “Interleukin 36 gamma”

Roswell Park Researchers Develop IL-36 Gamma 'Armored' CAR T Cells to Eradicate Solid Tumors

Tocilizumab Investigated for Acute Myocardial Infarction with Cardiogenic Shock

Immunology Market Evolution: Interleukin Inhibitors Rise as Biosimilars Reshape Treatment Landscape

Low-Dose Interleukin-2 Shows Promise in Slowing Motor Neurone Disease Progression in Landmark MIROCALS Trial

IN8bio's Novel Gamma-Delta T Cell Engager Shows Promise for Autoimmune Disease Treatment

Spectris Shows Promise in Reducing Alzheimer's Disease Dependence in Phase 2 Trial

Sobi Launches Phase 2a Trial of Gamifant for Interferon-Gamma-Driven Sepsis

Versamune HPV Shows Promising Survival Rates in Advanced Cervical Cancer Trial

UAB36 Gene Score Predicts Drug Resistance and Outcome in Breast Cancer

Gamma Secretase Inhibitors Show Complex Effects in Multiple Myeloma Treatment

Page 1 of 217